申请人:FERRING B.V.
公开号:US20160122386A1
公开(公告)日:2016-05-05
Compounds of formula (I), salts thereof, and compositions and uses thereof are described. The compounds are useful as V1a vasopressin agonists, for the treatment of, e.g., complications of cirrhosis, including bacterial peritonitis, HRS2 and refractory ascites.
公式(I)的化合物,其盐,以及其组合物和用途被描述。这些化合物可用作V1a加压素激动剂,用于治疗,例如,肝硬化并发症,包括细菌性腹膜炎,HRS2和难治性腹水。